Ely, United Kingdom

Ian M Gaylor

This inventor holds 2 USPTO granted patents. Top assignees: Cambridge Consultants Limited, Fisons Ltd.. Active years: 1996-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian M Gaylor. Retrieved from https://idiyas.com/inventor/ian-m-gaylor-oa36m7lf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ian M Gaylor: Innovator in Medicament Formulations

Introduction

Ian M Gaylor is a notable inventor based in Ely, GB. He has made significant contributions to the field of medicament formulations, holding a total of 2 patents. His work has had a meaningful impact on the pharmaceutical industry.

Latest Patents

Gaylor's latest patents include a process for the production of medicament formulations. This innovative process involves the production of compacted bodies of powdered medicament, which enhances the efficiency and effectiveness of drug delivery. Another notable patent is related to a fluid delivery system, which further demonstrates his expertise in creating advanced pharmaceutical solutions.

Career Highlights

Throughout his career, Ian M Gaylor has worked with reputable companies such as Fisons Ltd. and Cambridge Consultants Limited. His experience in these organizations has allowed him to develop and refine his skills in the field of medicament formulations.

Collaborations

Gaylor has collaborated with several professionals in his field, including David John Livesley and William G Dando. These collaborations have contributed to the advancement of his innovative ideas and patents.

Conclusion

Ian M Gaylor is a distinguished inventor whose work in medicament formulations has led to valuable patents and advancements in the pharmaceutical industry. His contributions continue to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…